Source: ERJ Open Res, 6 (1) 00217-2019; 10.1183/23120541.00217-2019
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mari Yamasue, Kosaku Komiya, Osamu Takahashi, Jun-ichi Kadota. Increasing mortality rate due to rheumatoid arthritis-related lung diseases in Japan. ERJ Open Res, 6 (1) 00217-2019; 10.1183/23120541.00217-2019

Member's Comments

No comment yet.

Related content which might interest you: Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease Source: Eur Respir J 2016; 47: 588-596 Year: 2016 Incidence, prevalence and mortality of rheumatoid arthritis-associated interstitial lung disease : a retrospective study Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Duration of rheumatoid arthritis and the risk of developing interstitial lung disease Source: ERJ Open Res, 7 (1) 00633-2020; 10.1183/23120541.00633-2020 Year: 2021 Risk factors of interstitial lung diseases in patients with rheumatoid arthritis. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Analysis of lung diseases associated with rheumatoid arthritis Source: Eur Respir J 2006; 28: Suppl. 50, 307s Year: 2006 Mortality and clinical features in rheumatoid arthritis and interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Predicting outcomes in rheumatoid arthritis related interstitial lung disease Source: Eur Respir J, 53 (1) 1800869; 10.1183/13993003.00869-2018 Year: 2019 Tobacco smoking and survival in lung cancer patients with rheumatoid arthritis Source: Eur Respir J 2006; 28: Suppl. 50, 702s Year: 2006 Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Are smoking and COPD associated with ILD onset in rheumatoid arthritis? Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Effect of respiratory pathology on the quality of life for patients, suffering from rheumatoid arthritis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Methotrexate and rheumatoid arthritis associated interstitial lung disease Source: Eur Respir J, 57 (2) 2000337; 10.1183/13993003.00337-2020 Year: 2021 Interstitial lung disease in patients with rheumatoid arthritis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Prevalence of pulmonary involvement in rheumatoid arthritis patients in Indian population Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Characteristics and predictors of outcome in rheumatoid arthritis related ILD Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Rituximab improves interstitial lung disease in rheumatoid arthritis patients Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Rheumatoid arthritis-related lung disease Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 The lung in rheumatoid arthritis: drugs versus underlying disease Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective Year: 2009 The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA) Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016